Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer-Reference-Cited by-同舟云学术

Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

Published:1997-06 Issue:6 Volume:8 Page:525-529
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Manegold C.,Bergman B.,Chemaissani A.,Dornoff W.,Drings P.,Kellokumpu-Lehtinen P.,Liippo K.,Mattson K.,Pawel J.v.,Ricci S.,Sederholm C.,Stahel R.A.,Wagenius G.,Walree N.v.,ten Bokkel-Huinink W.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/8/6/525/19480948/8-6-525.pdf

Reference30 articles.

1. Chemotherapy in non-small-cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials;BMJ,1995

2. Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: A phase II study;Abratt;J Clin Oncol,1994

3. Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: A phase II study;Anderson;J Clin Oncol,1994

4. Activity of gemcitabine in patients with non-small-cell lung cancer: A multicenter extended phase II study;Gatzemeier;Eur J Cancer,1996

5. Maximum-tolerated dose defined for single-agent gemcitabine: A phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer;Fossella;J Clin Oncol,1997

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status;Cochrane Database of Systematic Reviews;2023-07-07

2. Cisplatin-based combination therapy for cancer;Journal of Cancer Research and Therapeutics;2023

3. Combined Radiation Therapy and Chemotherapy as an Exclusive Treatment Option in Locally Advanced Inoperable Non-small Cell Lung Cancer;Medical Radiology;2021

4. Gemcitabine, Navelbine, and Doxorubicin as Treatment for Patients with Refractory or Relapsed T-Cell Lymphoma;BioMed Research International;2015

5. Effect of chemotherapy on quality of life in patients with non-small cell lung cancer;Supportive Care in Cancer;2014-02-22